参考文献/References:
[1]European Society of Cardiology (ESC),European Heart
Rhythm Association (EHRA),Brignole M,et al.2013 ESC
Guidelines on cardiac pacing and cardiac resynchronization
therapy:The Task Forceon cardiac pacing and resynchronization
therapy of the European Society of Cardiology (ESC) [J].Eu-
ropace,2013,15(8):1070-1118.
[2]Knackstedt C,Arndt M,Mischke K,et al.Depression,psycho-
logical distress,and quality of life in patients with cardioverter
defibrillator with or without cardiac resynchronization therapy
[J].Heart Vessels,2014,29(3):364-374.
[3]Slyngstad T,Huth Ruwald AC,Kutyifa V,et al.Cardiac resyn-
chronization therapy is associated with reductions in left atrial
volume and inappropriate implantable cardioverter-defibrillator
therapy in MADIT-CRT [J].Heart Rhythm,2014,11(6):1001-
1007.
[4]中华医学会心血管病学分会,中华心血管病杂志编辑委员
会.中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,
2014,42(2):98-122.
[5]De Boeck BW,Teske AJ,Meine M,et al.Septal rebound
stretch reflects the functional substrate to cardiac resynchroniza-
tion therapy and predicts volumetric and neurohormonal re-
sponse[J].Eur J Heart Fail,2009,11(9):863-871.
[6]Felker GM,Anstrom KJ,Adams KF,et al.Effect of Natriuretic
Peptide-Guided Therapy on Hospitalization or Cardiovascular
Mortality in High-Risk Patients With Heart Failure and Re-
duced Ejection Fraction:A Randomized Clinical Trial[J].JAMA.
2017,318(8):713-720.
[7]Leenders GE,De Boeck BWL,Teske AJ,et al.Septal Rebound
Stretch is a Strong Predictor of Outcome After Cardiac Resyn-
chronization Therapy [J].J Card Fail,2012,18(5):404-412.
[8]Oeing CU,Tschpe C,Pieske B.The new ESC Guidelines for
acute and chronic heart failure 2016[J].Her,2016,41(8):655-663.
[9]Swets JA.Measuring the accuracy of diagnostic systems[J].Sci-
ence,1988(240):1285-1293.
[10]Chen JY,Lin KH,Chang KC,et al.The Shortest QRS Dura-
tion of an Electrocardiogram Might Be an Optimal Electrocar-
diographic Predictor for Response to Cardiac Resynchronization
Therapy[J].Int Heart J,2017,58(4):530-535.
相似文献/References:
[1]程 林.重组人脑利钠肽用于重症急性心肌炎伴
心力衰竭患者治疗的临床研究[J].医学信息,2018,31(08):126.[doi:10.3969/j.issn.1006-1959.2018.08.042]
CHENG Lin.Clinical Study of Recombinant Human Brain Natriuretic Peptide in the Treatment of Patients with Severe Acute Myocarditis and Heart Failure[J].Journal of Medical Information,2018,31(01):126.[doi:10.3969/j.issn.1006-1959.2018.08.042]
[2]胡丽君.螺内酯联合曲美他嗪治疗慢性心力衰竭的疗效分析[J].医学信息,2018,31(08):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
HU Li-jun.Efficacy of Spironolactone Combined with Trimetazidine in the Treatment of Chronic Heart Failure[J].Journal of Medical Information,2018,31(01):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
[3]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Journal of Medical Information,2018,31(01):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[4]平兰芝,黄小楼,胡天俊,等.CaMKⅡ在心血管疾病中的研究[J].医学信息,2022,35(10):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
PING Lan-zhi,HUANG Xiao-lou,HU Tian-jun,et al.Research on the Role of CaMKⅡ in Cardiovascular Diseases[J].Journal of Medical Information,2022,35(01):59.[doi:10.3969/j.issn.1006-1959.2022.10.014]
[5]刘革铭,马洪俊,刘 毅,等.心力衰竭的机制及诊疗的研究[J].医学信息,2022,35(10):91.[doi:10.3969/j.issn.1006-1959.2022.10.022]
LIU Ge-ming,MA Hong-jun,LIU Yi,et al.Mechanism, Diagnosis and Treatment of Heart Failure[J].Journal of Medical Information,2022,35(01):91.[doi:10.3969/j.issn.1006-1959.2022.10.022]
[6]黄光明,赵兴昌,符显昭.水中运动联合中药内治对糖尿病大鼠心肌细胞凋亡和心功能的影响[J].医学信息,2022,35(11):72.[doi:10.3969/j.issn.1006-1959.2022.11.020]
HUANG Guang-ming,ZHAO Xing-chang,FU Xian-zhao.Effects of Aquatic Therapeutic Exercise Combined with Traditional Chinese Medicine Internal Treatment on Cardiomyocyte Apoptosis and Cardiac Function in Diabetic Rats[J].Journal of Medical Information,2022,35(01):72.[doi:10.3969/j.issn.1006-1959.2022.11.020]
[7]何玲玲,程淑芬.曲美他嗪联合琥珀酸美托洛尔治疗冠心病心力衰竭疗效观察[J].医学信息,2018,31(13):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
HE Ling-ling,CHENG Shu-fen.Therapeutic Effect of Trimetazidine Combined with Metoprolol Succinate in the Treatment of Coronary Heart Disease with Heart Failure[J].Journal of Medical Information,2018,31(01):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
[8]赵 维,廖荣宏,王爱华.糖皮质激素治疗心力衰竭疗效与安全性的Meta分析[J].医学信息,2018,31(14):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
ZHAO Wei,LIAO Rong-hong,WANG Ai-hua.Meta-analysis of the Efficacy and Safety of Glucocorticoids in the Treatment of Heart Failure[J].Journal of Medical Information,2018,31(01):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
[9]施国富,吴春阳,施亚明,等.血浆脑钠肽对射血分数保留心力衰竭患者的诊断价值研究[J].医学信息,2018,31(16):47.[doi:10.3969/j.issn.1006-1959.2018.16.013]
SHI Guo-fu,WU Chun-yang,SHI Ya-ming,et al.Diagnostic Value of Plasma Brain Natriuretic Peptide in Patients with Heart Failure Preserved by Ejection Fraction[J].Journal of Medical Information,2018,31(01):47.[doi:10.3969/j.issn.1006-1959.2018.16.013]
[10]李 宁,胡硕强.心脏再同步治疗心力衰竭的文献计量分析[J].医学信息,2018,31(19):79.[doi:10.3969/j.issn.1006-1959.2018.19.024]
LI Ning,HU Shou-qiang.Bibliometric Analysis of Cardiac Resynchronization in the Treatment of Heart Failure[J].Journal of Medical Information,2018,31(01):79.[doi:10.3969/j.issn.1006-1959.2018.19.024]